Skip to content
Search

Latest Stories

Delay in relaxing Covid restrictions hit Asos sales

DELAY in the easing of Covid-19 restrictions and harsh summer weather led to a slowdown in sales at Asos last month, The Times reported.

The online retailer registered a 27 per cent increase in the group’s revenue to £1.29 billion in the four months to June 30, backed by surge in sales.


The business hailed it as “strong, against a backdrop of continued restrictions on consumers, volatile demand and increased global supply chain pressures”.

Asos, which is focused on young shoppers, said that sales in the past three weeks were muted as young people’s hopes of going out in groups on June 21 dashed following the delay in lifting restrictions.

This resulted in reduced sale of going-out dresses.

Besides, the rainy summer in the UK dampened demand for summer outfits.

In the wake of global uncertainty due to the pandemic, the company expected growth in the fourth quarter to be comparable with last year and full-year adjusted pre-tax profits to be in line with expectations.

This adjustment would strip out £6 million of interest charges related to its £500m bond issue in April and costs associated with its recent £295m Topshop acquisitions.

Asos disclosed underlying sales figures for the last quarter, which showed a slower rate of growth than its reported figures as its level of customer returns was lower than it estimated.

As a result, its fourth-quarter sales in 2020 were higher at £1.1bn than the £1.01bn that it reported last year. Its underlying growth during this quarter was 17 per cent, or 21 per cent at constant currency, rather than the 27 per cent reported growth.

Founded in 2000 by Nick Robertson, Asos is currently valued at £4.68bn, but is still listed on London’s junior Aim market.

“Although mindful of the continued impacts of the pandemic on our customers in the short term, we believe that the structure of the global ecommerce fashion market has changed for ever, which will drive an increase in online fashion sales over the long term,” said Nick Beighton, Asos chief executive.

“We’re excited about the size of the prize ahead of us and the opportunity of delivering on our ambition of being the number one destination for fashion-loving twentysomethings,” he said.

Earlier this week, the company announced to sell Topshop and selected Asos ranges in Nordstrom shops in the US.

More For You

Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
Grant Thornton's Anuj Chande urges UK firms to tap booming India

Anuj Chande

Grant Thornton's Anuj Chande urges UK firms to tap booming India

INDIAN companies are well placed to support the UK’s economic growth, Eastern Eye has been told by Anuj Chande, partner and head of the South Asia Business Group at Grant Thornton.

He was speaking after the publication of Grant Thornton’s India Meets Britain Tracker 2025: The latest trends in Indian investment in the UK, which was released last week. While companies in India need little encouragement to enter the UK market, the reverse is not true.

Keep ReadingShow less
India-US trade talks collapse over tariff disputes

FILE PHOTO: US president Donald Trump and Indian prime minister Narendra Modi shake hands as they attend a joint press conference at the White House in Washington, D.C., U.S., February 13, 2025. REUTERS/Kevin Lamarque.

India-US trade talks collapse over tariff disputes

TRADE talks between India and the US have hit a roadblock over disagreements on import duties for auto components, steel and farm goods, Indian officials with direct knowledge said, dashing hopes of reaching a deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

The deadlock marks a sharp shift from earlier optimism, following Trump's claim that New Delhi had proposed a "no tariffs" agreement for American goods, and officials from both sides suggesting India could be among the first countries to strike a deal on the new US tariffs.

Keep ReadingShow less